Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Cantor Fitzgerald

Generated: December 12, 2017

DrugPatentWatch Database Preview

Tentative Approvals for: Hetero Labs Unit Iii

« Back to Dashboard

Applicant Generic Name NDA Strength Dosage Form
Hetero Labs Unit Iiilamivudine; nevirapine; zidovudine202157150MG; 200MG; 300MGTABLET; ORAL
Hetero Labs Unit Iiidarunavir ethanolate202083400MGTABLET;ORAL
Hetero Labs Unit Iiiritonavir204587100MGTABLET;ORAL
Hetero Labs Unit Iiidarunavir ethanolate202083600MGTABLET;ORAL
Hetero Labs Unit Iiiemtricitabine; tenofovir disoproxil fumarate201806200MG; 300MGTABLET; ORAL
Hetero Labs Unit Iiidarunavir ethanolate202083150MGTABLET;ORAL
Hetero Labs Unit Iiimaraviroc203347300MGTABLET;ORAL
Hetero Labs Unit Iiimaraviroc203347150MGTABLET;ORAL
Hetero Labs Unit Iiidarunavir ethanolate202083300MGTABLET;ORAL
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Harvard Business School
Fish and Richardson
Federal Trade Commission
Cantor Fitzgerald
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: